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Report of the Synthetic Biology, Politics, and Philosophy Workshop  
Introduction and Summary: 
This report summarises the outputs of a workshop that took place at the University of Bristol, UK, in 
conjunction with the Social Science Research Group at the University of West England, Bristol and the 
BrisSynBio1 Synthetic Biology Research Centre on the 8th June 2017. 
 
The workshop brought together a number of social scientists, philosophers, computational biologists, 
genetic engineers, and artists working on synthetic biology to stimulate multidisciplinary deliberation and 
insights into the political challenges and philosophical ideas emerging at the cutting edge of innovation in 
synthetic biology. 
  
The event was coordinated by Darian Meacham (Director for Responsible Research and Innovation at 
BrisSynBio) and Miguel Prado Casanova in conjunction with BrisSynBio.  BrisSynBio is a multi-disciplinary 
research centre that focuses on the biomolecular design and engineering aspects of synthetic biology, and 
has been established as one of six Synthetic Biology Research Centres in the UK.  BrisSynBio is funded 
predominantly by the BBSRC and EPSRC, and has a number of other academic, industrial and public-facing 
partners. Responsible Research and Innovation (RRI) is a cross-cutting theme in the centre. Its offices are at 
the University of Bristol Life Sciences Building, Tyndall Avenue, UK BS8 1TQ.  As a BBSRC/EPSRC Synthetic 
Biology Research Centre, BrisSynBio is one of the leading research centres in the UK on synthetic biology.  
The event was organised as an activity of the NAPSTER Project2 (New Anthropology in Philosophy, Science, 
Technology and Engineering Research), funded by the University of the West of England, Bristol.  
 
This report has been adapted to inform the deliberations taking place on synthetic biology at the UN 
Convention on Biological Diversity (CBD), and as such we focus primarily on presenting the morning 
sessions of the Bristol Workshop.  In particular this report, and the conclusions drawn from it, responds to 
the call for information to be submitted in document SCBD/SPS/DC/DA/MW/86375 on “Research, 
cooperation and activities noted in the sub-paragraphs (a) through (c)” below, and taking into account 
“socio-economic, cultural and ethical considerations” as stated in the preamble: 
 
(a) To conduct research on the benefits and adverse effects of organisms, components and products of 
synthetic biology technologies and approaches on biodiversity, with a view to filling knowledge gaps 
and identifying how those effects relate to the objectives of the Convention and its Protocols; 
 
(b) To promote and enable public and multi-stakeholder dialogues and awareness-raising activities on 
the potential benefits and potential adverse effects of organisms, components and products of 
synthetic biology technologies and approaches on biodiversity, involving all relevant stakeholders 
and with the full and effective engagement of indigenous peoples and local communities; and 
 
(c) To cooperate in the development of guidance and capacity-building activities with a view to 
assessing the potential benefits and potential adverse effects of organisms, components and 
products of synthetic biology technologies and approaches and, if necessary, updating and adapting 
current methodologies for risk assessment of living modified organisms to organisms resulting from 
synthetic biology, as appropriate. 
*Summary Conclusions of the workshop can be found on page 8. 
                                                          
1 http://www.bristol.ac.uk/brissynbio/ 
2 www.newanthropology.eu 
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Morning session:  
Responsible Research and Innovation and the 
Politics of Synthetic Biology 
 
Chaired by Prof. Julie Kent (University of West England and BrisSynBio) 
10:00-11:00 Michael Reinsborough (BrisSynBio Research Fellow, University of Bristol and University of West 
England) 
Title:  Social science and philosophy within the context of developing Responsible Research and Innovation: 
integrated AREA 
Summary 
Since the discussions of the workshop were bringing together philosophers and social scientists the opening 
speaker proposed to describe the context of this possibility to work together.  ‘Responsible Research and 
Innovation’ (RRI) was a new policy term to describe a changing approach to the relationship between science 
and society.  The old linear model had been “pay for basic science and leave scientists alone and this will, in 
the long run, generate applications that will benefit to the economy and society”.  But this rhetoric justifying 
funding was now largely being replaced.  The new model “Grand Challenges – research should be useful to 
society and address grand challenges in society and/or global society”.  Large corporate research 
laboratories, example Bell Labs, have largely disappeared in the changing (post-Fordist) structure of the 
economy.  There has also been a long term recognition of the Collingridge Dilemma: that with new 
technologies we haven’t enough knowledge to effectively regulate them; but by the time we have enough 
knowledge the technologies are well established (path-dependency) and therefore difficult and expensive to 
change.  Thirdly, there is a growing recognition that what begins in the lab (if it is successful) becomes a 
generalized product, technique, or knowledge outside the lab.  And therefore how is it that we might pull 
society into the lab so that what comes out of the lab is integrated to the needs of communities.   
While there are several models for integrating social/societal concerns to research agendas this presentation 
focused on the so-called AREA model promoted in the UK by the Environmental and Physical Sciences 
Research Council (EPSRC).  AREA stands for Anticipate, Reflect, Engage, Act.  The qualities of being 
anticipatory (being aware of how expectations of the future influence the present; using a multiple scenarios 
approach), reflexive (researcher awareness of their own position within the greater research economy), 
inclusive (broadly inclusive as a deliberative, responsive (mutually responsive to dialogue with others within 
and outside of the immediate research community) are to be integrated into research agenda.  While this 
does not guarantee consensus from all the various parties it is hoped that the integration of science will be 
improved and research trajectories will begin to better reflect societal concerns. 
Discussion with Workshop Participants 
Questions after the presentation focused on anticipation of benefits and risks of synthetic biology, and how 
a multiple scenarios approach to anticipating possible futures could be more accurate (by developing 
researcher and community capacity).  The presenter maintained a position that while more speculative 
methods and ideas about the future were inevitable, it was important to remember that images and visions 
Synthetic Biology, Politics, and Philosophy Workshop 
 
Workshop Report from June 8, 2017 at University of Bristol, Life Sciences Building, Tyndall Avenue, UK BS8 1TQ  3 
of the future are often mobilized to justify resources for research.  In this context, it seems more important 
that future claims about benefits and risks are plausible and to adhere to the precautionary principle.    
One participant shared an example where serious consequences of a new vaccine trial for swine flu had not 
been anticipated, but which possibly could have been avoided if scientists had been required to consider 
possible multiple scenarios and outcomes. 
Slides and references to this presentation are in the appendix 2. 
 
11:15-12:00 Lewis Coyne (Department of Sociology, Philosophy, & Anthropology, University of Exeter; 
member of www.ethicsandgenetics.org) 
Title: Questions about Responsibility in Synthetic Biology 
Summary 
This talk assessed the pros and cons of the responsible research and innovation agenda (RRI), as a way of 
regulating the development of synthetic biology. Two broad reasons were given why RRI, which involves the 
public and civil society in the early stages of the innovation process, is preferable to peer-regulation (or self-
governance) by researchers and innovators alone. The first reason was the greater understanding of risks 
that RRI can allow for. The second was the greater degree of ethical scrutiny that it allows. It was argued that 
the involvement of the public and civil society will allow us to make better informed decisions about 
synthetic biology, and better understand the ethical concerns it raises. 
To show how this might work in practice, the talk gave the hypothetical example of a synthetic biology 
coffee plant that could grow in temperate climates such as the UK's. This led to a discussion regarding the 
socio-economic condition of developing world farmers, as their livelihoods would likely be negatively 
affected by the introduction of a patent-protected crop such as this to the global marketplace. Since 
synthetic biology could raise such issues of global justice, it was argued that an ideal regulatory framework 
would be able to accommodate them, and RRI, at least in principle, allows for this. 
However, it was also argued that RRI is neither rigorous nor comprehensive enough. Two problems were 
raised with the agenda. The first was that there is no necessary link between legislation and any concerns 
raised by the public and civil society. The second problem was that RRI is only able to accommodate 
concerns about certain undesirable consequences of synthetic biology, and cannot accommodate any 
fundamental objections to it.  
The overall argument was that, to be truly responsible, research and innovation in synthetic biology should 
be subject to national and international legislation following from public deliberation. In particular, if the 
public and civil society overwhelmingly raise fundamental objections to synthetic biology, then national and 
international legislation ought to reflect this. 
The text of this presentation is given in the appendix 3. 
Discussion with Workshop Participants 
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One participant raised the issue of the precautionary principle and whether governance ought to abide by it. 
The presenter argued that national and international governance should be in accordance with the 
precautionary principle where there are credible risks of major ecological harm or negative socio-economic 
consequences for the globally disadvantaged. 
Another participant asked whether issues of global justice were too ambitious for legislation at the national 
and even regional levels (for example, the European Union). The presenter accepted this criticism, and 
argued that national and regional legislation might help build support and consensus for international 
legislation at the level of the United Nations. 
 
12:00-:12.45 Molly Bond (School of Geographical Sciences, University of Bristol) 
Title: Synthetic Biology Assemblages: Friction at the Interface of Diversity 
Summary 
This talk addressed one aspect of the speakers’ research on the governance of synthetic biology and the 
network of actors, ideas, and economic agendas which contribute to knowledge-making and decision-making 
about the future of synthetic biology. The network that has formed around synthetic biology was 
conceptualised as an assemblage. The synthetic biology assemblage incorporates governments and 
regulators from around the world: NGOs, and CSOs, a variety of social, ecological, and physical scientists; 
industry associations, businesses, and venture capitalists; farmers and farmer organisations; Indigenous 
peoples and associated organisations; trade unions; the UN and other international and financial agencies. 
Within these groups dominant and influential discourses circulate, such as ‘disruptive innovation’, 
‘responsible research and innovation’, ‘human rights’, the ‘rights of Nature’, and ‘living in harmony with 
Nature’. Many in this assemblage are guided by different economic agendas or visions, including the 
‘Bioeconomy’, ‘Green Economy’, ‘Buen Vivir’, ‘Circular economy’, and ‘Sustainable Development’.  
Each actor, discourse, and economic agenda within this assemblage carries different interpretations of 
sustainability, risk, and the ‘good life’, as well as the type of relationship envisaged between society, 
economy, nature, and natural resources. Between this diversity of world-views, knowledge-systems, 
sciences, and relations, ‘friction’ is generated. Friction, in a physical and metaphorical sense, is the result of 
diverse elements interacting, interrupting, colliding, connecting, or encountering one another. Friction is a 
force that can be reactive or erosive, but always productive. Friction then, produces both positive and 
negative outcomes for different elements in the assemblage. The main argument of the talk was that instead 
of avoiding or fearing friction, as many in the synthetic biology assemblage do, it should be embraced as a 
reality. Friction reveals deep ontological conceptions of the way the world is and ethical commitments about 
the way it should be, including what constitutes human progress. Friction is a result of diversity, occurring at 
the interface of diversity, and it is diversity and plurality that makes society more resilient to future 
challenges. 
Discussion with Workshop Participants 
One participant suggested that the main purpose of the responsible research and innovation agenda is to 
iron out ‘friction’, or the diversity of worldviews and perspectives on synthetic biology, so that eventually the 
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public would accept genetic engineering or synthetic biology. Another participant agreed that the big issue 
for the future of synthetic biology was public consent to this new science and that would be highly frictious. 
The ensuing discussion highlighted how some parties at the Convention on Biological Diversity were 
advocating the idea of ‘sciences for life’, where sciences and technologies deriving from traditional 
knowledge are being put forward as alternatives to synthetic biology. It was also noted that other parties 
advocate a moratorium on synthetic biology until there is greater clarity on all likely socio-economic, ethical, 
and cultural consequences. It was argued in response, that such strongly held views about the way the 
future could be shaped by synthetic biology inevitably had to be taken into account at the CBD in order to 
respect different agendas and to govern democratically. 
 
 
Afternoon session:  
Concepts of Nature and Science 
 
Chaired by Dr Maria Fannin (University of Bristol) 
14:00-14:45 Thomas Gorochowski (BrisSynBio, University of Bristol) 
Title: Automation and Synthetic Biology 
Summary 
This talk introduced the complexity of biology, and the many challenges scientists face in precisely 
engineering and scaling up innovations in synthetic biology. Increasing automation and the combination of 
artificial intelligence and ‘deep learning’ however, are rapidly making biology easier and faster to engineer, 
with productivity increasingly outpacing Moores law. The talk summarised the array of new techniques and 
capabilities of cutting edge synthetic biology tools and automated systems, including MAGE (multiplex 
automated genetic engineering) to accelerate evolution and optimise metabolic pathways; 3D printing 
technologies capable of bioprinting using biological living ink; as well as new distributed manufacturing 
technologies, such as ‘Digital to Biological Converters’ (DBC) capable of  transmitting DNA sequences digitally 
to manufacture RNAs, proteins or viral particles outside normal laboratory conditions such as in Outer space. 
These distributed manufacturing technologies are also being promoted by companies such as Transcript to 
enable so-called DIY Bio or the ‘democratisation of synthetic biology’, where portable lab space can be 
moved around in containers and rented out for synbio start-up companies.  
Discussion with Workshop Participants 
One participant asked whether framing synthetic biology and other emerging technologies in terms of 
‘democratisation’ was misleading. The reason was that although synthetic biology is highly accessible to the 
public, since it can be practiced at a minimal cost outside professional research institutes, this means that it 
easily falls outside of public scrutiny and oversight, and that if the effects of synthetic biology are not publicly 
accountable, then it might in fact be less democratic than traditional biology. Further discussion centred 
around the question of how automation technologies were changing or could potentially change the 
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methods of science and the traditional role of the scientist in the scientific endeavour. Specifically, there was 
discussion of how automation technologies in synthetic biology were impacting (decreasing) the idea of the 
biological sciences as hypothesis driven.    
 
15:15-15:50 Katy Connor (BrisSynBio Artist in residence) 
Title: “Blood Culture”: Reimagining Life at the Cellular level 
Summary 
This talk presented some of the early work emerging from an art, science and social science collaboration, 
exploring how artistic research can bring new insights to the practice of cell culture - in particular to culturing 
red blood cells, synthetic blood - currently being produced in the lab by researchers at BrisSynBio. 
As a starting point, the artist considered the aesthetics of blood at the cellular level; contrasting the black 
and white images derived from microscopy technologies and the instrumental use of colour for lab research 
purposes, with a cultural (and visceral) understanding of blood - particularly in relation to its liquidity. The 
talk also considered what potentialities creative practice, art and science had for public deliberation, 
engagement and exploration of diverse views and values.  
Discussion with Workshop Participants 
Participant discussion focused on the ways in which artistic practice can be informative to scientists and 
collaborators, in revealing how their own work depends on particular (often unexamined) visual strategies.  
 
 
15:50-16:25 Miguel Prado Casanova (Department of Health and Social Sciences, University of West England) 
Title: Functional Noise and Synthetic Biology 
Summary 
This talk presented a critique of the concept of noise in bioinformatics frameworks for synthetic biology 
where the biological system is to be reduced to the signal from various background noise in the 
bioinformatics method.   The aim is to develop, an understanding of the theoretical and practical role of 
“noise'”, as a form of randomness, in biological organization and evolution within the context of synthetic 
biology.  Phrases such as ‘junk DNA’ give a sense that foreground information not understood by geneticists 
does not have a biological meaning.  According to some ideas from evolutionary biology, beginning with 
Darwin, and including recent work by Giuseppe Longo, Cristian S. Calude (2015), and Barbara Bravi (2016), 
physical randomness, if properly understood, should not be seen as “noise” in complex systems.  This is 
particularly true of living systems, where randomness has a functional role that contributes, in an essential 
way, to the structural stability of system dynamics.  Thus, it is important to recognise the development of a 
biological organism in relation to background noise; noise has a functional role in the development of 
organisms, perhaps in the same way that the development of an child’s immune system requires an 
adequate background of germs/microbial threats in order to initially form and then develop into a healthy 
immune system.   
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Discussion with Workshop Participants 
Participant discussion explored the ways in which informational frameworks for understanding biology were 
adapted from thermodynamic frameworks (signal/noise) for making communication systems functional.  
And subsequently, whether or not this was an appropriate manner of conceptualising noise in biological 
systems which had evolved within ‘noisy’ environments anyway, and wherein noise could play a 
developmental role.  
 
16:25-17:00 Massimiliano Simons (University of Leuven, Belgium) 
Title: Synthetic biology as ready-made nature in the making 
Summary  
This talk presented a typology of constructivist philosophies (that in some way our knowledge of the world is 
constructed/constructs that world), emphasizing that not all constructivist philosophies are the same.  The 
increased use of computers and engineering methods in biology (computational biology) is in many ways 
consonant with constructivist philosophies.  The central claim was that, although earlier periods of molecular 
biology (such as genetic engineering) can clearly be seen as constructivist as well, within the last decades 
there is a shift. The author introduces the notion of ‘postcomplex life sciences’ that implies that new 
approaches do not deny the complexity of nature, but imply a desire to transcend it by an open constructive 
act. This constructive attitude is expressed in different ways: if nature is too complex for our models … then 
(1) … make models more complex, e.g. systems biology; or (2) … make nature less complex, e.g. synthetic 
biology.   In synthetic biology the construction process is in the open, in the sense that synthetic biologists 
argue that even if biological systems do not have standard parts, are not modular, perhaps we can make 
them so. 
Discussion with Workshop Participants 
Participant discussion examined the ways that critique of constructivist social theory might also apply to 
constructivist biology.  The discussion also considered what an ‘open’ science was and if there are more than 
one form of an ‘open’ science made possible in the new biology.   
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Conclusions of workshop: 
The conclusions drawn below reflect key considerations and outputs of the workshop that were most 
relevant to the ongoing work on synthetic biology at the CBD and the recent call for information. These 
considerations included:  
Responsible Research and Innovation and the Politics of 
Synthetic Biology 
• The importance of Anticipation, Reflection, Engagement and Action in R&D processes can be 
emphasized.  The beginning point of all innovation is in the lab and therefore research is an early 
location to consider societal outcomes. 
• The responsible research and innovation agenda is a step in the right direction for governance of 
synthetic biology, as the formal involvement of civil society organisations and the public can allow 
for better-informed and more accountable policy making. 
• Considerations of environmental and global justice, including socio-economic, cultural and ethical 
considerations are unavoidable, and so should be incorporated into any ideal international 
governance framework for synthetic biology. 
• The precautionary principle has been and remains foundational for all risk assessment frameworks 
governing new technologies, including synthetic biology. Such that activities which pose a significant 
risk to planetary ecology, or a risk to human dignity simpliciter, shall be preceded by an exhaustive 
examination; their proponents shall demonstrate that expected benefits outweigh potential harms, 
and any potential harms should be fully understood and mitigated. 
• Continuing levels of politics, conflict and ‘friction’ amongst different economic agendas, world views, 
systems of knowledge and vested interests within parties to the CBD and across relevant 
organisations, Indigenous peoples and Local communities will not be easily aligned, therefore a 
system must be found to accommodate and govern fairly and equitably for all.  
 
Concepts of Nature and Science 
• Synthetic biology combining with artificial intelligence, and increasingly capable automation 
technologies, makes biology easier and faster to engineer, with companies increasingly capable of 
producing bespoke chemicals, compounds and products on demand.  
• Some conflicts were identified around DIY bio and the idea of the ‘democratisation’ of genetic 
engineering.  Giving more actors access to all technologies is not the same as having a dialogue 
about how we want to use them, or what types of uses might be appropriate; greater access to 
technologies and wider proliferation does not automatically equate to greater democratic oversight 
or legitimation of technologies, and could in some cases lead to the inverse.  
• The development of a biological organism is always in relation to background noise.  So some 
metaphors (taken from communication theory) for noise reduction in synthetic biology may be 
inappropriate to biological systems. 
• There are a number of ways in which biology is becoming ‘constructivist’ which is to say humans are 
actively making with their biological knowledge. 
• Postcomplex life sciences are not necessarily a denial of the complexity of nature, but a desire to 
transcend it. 
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Appendix 2 Slides of Presentation on RRI (AREA Model) 
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Appendix 3 Text of Presentation Questions about Responsibility in Synthetic Biology (Lewis 
Coyne, University of Exeter) 
 
 
Questions about Responsibility in Synthetic Biology 
1. Introduction 
The Responsible Research and Innovation (RRI) agenda, as defined by the European Commission, has two 
broad functions: to (a) build public trust in research and innovation by (b) recognising the legitimacy and 
necessity of public and civil society groups influencing scientific and technological development, particularly 
in its early stages. I will here set out some reasons why RRI – in this form – is preferable to peer-regulation by 
researchers and innovators which does not subscribe to (b). I will also, however, ask whether RRI is rigorous 
and comprehensive enough. 
Since this is a conference on RRI and its relation to synthetic biology, I assume that all of us present accept 
that the latter ought to be subject to some sort of ethical scrutiny – the only questions being what form that 
takes and who does it. But occasionally people ask, partly in jest, why humanities scholars enjoy a right to 
unrestricted research while scientists do not. The answer, of course, is that while freedom of expression is 
conceivably an absolute right, there is no equivalent right to freedom of action. We regulate action where 
there is the risk of wrongdoing and harm to others.  
Modern natural science (i.e., since the 16th century) is distinguished from pre-modern science by its 
emphasis on experimentation, from which theory subsequently follows. Doing something in the world, and 
deriving knowledge therefrom, is its hallmark. As such, modern science – both natural and social – is 
inseparably tied to action. If this is true for the research stage, it is self-evidently the case for that of 
development, and, since synthetic biology is intended for industrial application, it falls under the remit of 
ethical scrutiny in both respects. 
2. Epistemic Expertise 
The question, then, is what sort of regulation is proper to an innovation like synthetic biology. One option is 
peer-regulation, which is roughly the function of university ethics panels. Of course, these tend to operate 
within individual institutions. However, for an example of this model working across institutions we may 
point to the 1975 Asilomar Conference on Recombinant DNA – an early form of genetic engineering – where 
practitioners drew up a voluntary set of regulatory guidelines. Or, for a more contemporary example, we 
could point to the 2015 International Summit on Human Gene Editing. (It should be clear that I am using 
‘regulation’ here in a very broad sense, covering even voluntary ethics codes and guidelines). 
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Let’s take these latter examples as ideal forms of peer-regulation because of their inter-institutional 
composition. Such an approach appeals to what we could call epistemic expertise. In other words, expert 
practitioners might be seen as best placed to perceive any possible risks, dangers, and misuses of a new 
technology, since they have the greatest understanding of what are after all complex innovations. The 
obvious next step of the argument is that this would lead to the best-informed regulation, and can be 
confidently adopted on a voluntary basis. In some cases, those who refuse to do so might be considered 
irresponsible, and subjected to social sanctions within the scientific community. 
One concern we might have with this argument is the questionable appeal to epistemic expertise. Take, as 
another example of this approach, the financial sector. Wall Street and the City of London have in recent 
decades been increasingly allowed to regulate themselves partly on the assumption of epistemic expertise: 
that those who know most about complex financial instruments are best placed to identify risks and avoid 
harms. But after the financial crisis we are not inclined to take such an argument seriously. 
Why is this? Partly there is the suspicion of moral corruption: that bankers were willing to take high-risk 
decisions in pursuit of a quick buck. But even if we assume absolute moral integrity on the part of the actors, 
the problem is that epistemic expertise of a part – sub-prime mortgages, say – does not equate to epistemic 
expertise of the whole in which they are embedded: in the case of banking, national and global economic 
activity. And it is precisely the risk of adverse effects on others within that whole which concerns us. 
Now, something similar might also prove to be true of synthetic biology. Those who best understand it are 
not necessarily best placed to understand the wider effects it might have – ecological or socio-economic – 
and whether those wider effects include the risk of harm. If this is the case, or at least a distinct possibility, 
then we would have reason to be dubious about peer-regulation alone. 
So how might we eliminate, or at least decrease the likelihood of, the possibility of harm to others? As 
stated, the RRI agenda holds that a variety of public voices and civil society organisations should be invited to 
inform the innovation process. The immediately obvious strength of this approach is that it better 
corresponds to the contextual whole within which innovation takes place. If, for example, agricultural 
synthetic biology risks adverse ecological effects, then a variety of perspectives might be better placed to 
capture this: wildlife organisations, and so on. And if they are wrong, and fears are ungrounded, they can be 
publicly proven so – possibly building greater trust in the innovation.  
 
According to the criterion of epistemic expertise, then, RRI would seem, at face value, to be superior to peer-
regulation alone. 
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3. Optimising Ethical Scrutiny 
A second advantage relates to what we might call the optimisation of ethical scrutiny.  
Let’s look at peer-regulation in this regard. An advocate of this model would have to assume that either 1) 
the scientific community in question is sufficiently able to identify and act in accordance with the 
appropriate ethical standards, or 2) that ethics is not its concern. The latter is clearly untenable: if what is 
good and right is what we should do, then we cannot say that we needn’t worry about it. (None of us, I hope, 
really want to see innovation which flouts academic integrity, physically harms others, or violates human 
dignity.) 
The former assumption is also questionable – and not a slight on synthetic biologists, since we should be 
sceptical that any one group can perceive all ethical concerns relevant to a particular issue, and act 
appropriately in response. For the record, I take this to be true even of applied ethicists: being an expert in 
moral philosophy doesn’t amount to being a moral saint. We might – and I stress might – be good at 
identifying what we should do, but we aren’t necessarily good at doing it! 
How does the RRI agenda fare in this regard? RRI explicitly seeks to align innovation with widely-held values 
and standards, by opening the process up to a range of voices from the public and civil society. Once again, 
this looks more promising than peer-regulation. Allowing for scrutiny by a variety of perspectives seems 
likely to strengthen critical reflection through challenging assumptions, and highlighting possible 
consequences.  
On this basis we might then be better able to locate areas of ethical concern, particularly, I would suggest, 
regarding marginalised groups and those who are not easily able to represent themselves. And again, if 
those fears are unfounded they can be publicly proven so. 
Let’s take, as an example, the economic interest of agricultural labourers in the developing world. Some 
might dispute the notion that we have any obligations toward, for example, a coffee farmer in Ethiopia. But 
if most of us want to see those in the developing world live dignified lives, as I assume we do, and if self-
sufficiency and prosperity generally contribute to such a life, as I believe they do, then we should be 
concerned with the fortunes of farmers in the developing world. 
 
Now, let’s say that a synthetic biologist working with a food company develops a coffee plant which can 
grow in a greater range of climactic conditions, such as the UK’s temperate climate. (I don’t know if that’s 
biologically feasible, but for the sake of argument let’s assume it is.) The genome is patented with the hope 
of being brought to market. Our Ethiopian farmer would then be in competition with a more economical 
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strain, potentially undercutting his ability to sell to us. Moreover, if he wanted to grow that crop he would 
presumably have to do so with permission of the intellectual property holder. 
One can probably imagine the kind of complex legal and socio-economic questions raised here. Should we 
allow both traditional and synthetic strains of coffee to compete on the market, letting consumer preference 
run its course? Or should we protect the Ethiopian farmer’s interests by, say, taxing synthetic products? 
Should we allow the synthetic coffee to be sold like any other coffee, or should we clearly demarcate its 
origin on the packaging, allowing for informed consumer decision-making? If the Ethiopian farmer wanted to 
grow the synthetic strain, for whatever reason, what would he owe to the company who owns the patent? 
What will that do for his autonomy? And so on. 
I don’t pretend to have definitive answers to these questions. But RRI at least makes it possible for our 
Ethiopian farmer, and others like him, to be taken seriously during the innovation process and its application 
to the market. We would have a better chance, at least, of taking his well-being into account than we do 
courtesy of the peer-regulation model. 
So on two counts – epistemic expertise and optimising ethical scrutiny – the RRI agenda appears preferable 
to peer-regulation alone. 
 
4. Limitations of RRI 
I don’t want to give the impression, based on what I have said so far, that I think RRI is an ideal regulatory 
agenda – on the contrary, there are serious limitations to this approach, some in principle and others more 
practical. For the sake of time I will pick just two objections, the first practical in nature, the second more of 
principle. 
(α) The Legislative Gap 
Firstly, there is the issue of how RRI could inform appropriate legislation. At present, the RRI agenda is simply 
a ‘tool kit’ with no obvious way of feeding into law; indeed, it makes no claims to do so. Although some 
funding for innovation might be withheld by major funding bodies if practitioners refuse to engage with the 
agenda, this is only a soft kind of power rather than an enforcement. 
 
Why is this a problem? Well, as I suggested earlier, being responsible involves not just knowing what we 
should do, but also actually doing it. Even if we all agreed that there were ways in which an innovation ought 
not to be employed, this is, of course, no guarantee that practitioners would act accordingly. Regulation by 
national law and international treaties, however, are usually better able to ensure this. To be sure, 
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legislation is not a panacea: regulating in one nation or geopolitical region – the EU, say – risks ‘ethics 
dumping’, where companies and researchers simply go to states with more favourable regulatory conditions. 
Following Brexit one can easily see the UK taking on such a role in Europe. 
 
But does this mean that we should simply give up on regulation otherwise deemed appropriate? Obviously 
not: firstly, because if, hypothetically, we think we should regulate an innovation in a particular way then 
that is what we should do! And secondly, on a slightly less idealistic note, attempting to generate standards 
on an international level can at least avoid a race to the bottom. It is hard to do so, no doubt, but not 
impossible, and the difficulty of international co-ordination does not mean we should not try. 
 
It is of course the case that peer-regulation also suffers from the same problem of the legislative gap, so I am 
not claiming that RRI is worse than peer-regulation in this regard – merely that it, too, is not ideal. 
 
(β) Fundamental Objections 
My second concern is to do with the ethical scope of the RRI agenda. As stated, RRI seeks to draw on widely-
held values and standards, partly to build public trust in scientific and technological innovations such as 
synthetic biology. This might be adequate if we only have partial concerns about the consequences of an 
innovation, and which can be addressed through appropriate regulation. So with the example I gave earlier, 
of an Ethiopian coffee farmer’s prosperity and autonomy, it is conceivable that the RRI agenda could lead to 
some consideration of his interests (although, as I say, there is no obvious way these would be reflected in 
legislation). 
But what if an overwhelming majority of the public have fundamental objections to an innovation? What do 
we do then? Could these objections be incorporated? I would suggest that they cannot. Here we find a 
tension in the underlying aims of the RRI agenda, which assumes that the innovation is going to take place 
and asks only for the public to shape its development so as to avoid specific consequences. But this means 
that if the public and civil society don’t want a certain technology to develop at all their objections fall 
outside the scope of the RRI agenda. And in that case, public trust in innovation will presumably be 
undermined, rather than enhanced. 
It seems to me that good democratic governance does not lightly override public opinion (though it may do 
on occasion), and if the public does have well-founded, fundamental objections to an innovation then these 
ought to be taken into account. And if our regulatory agenda cannot capture and respond to such objections 
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– and it seems RRI cannot – then there is something wrong with the regulatory agenda, not with the 
objections. 
Now, it might be that synthetic biology doesn’t elicit such a response from the public, or not on a significant 
scale. If that is the case, then the demands placed on synthetic biology by the RRI agenda might be sufficient. 
But we at least need to find out first – so I will end by posing some questions of principle which require 
answers, answers which can only come from deliberation in the public realm. 
Is it hubristic to create new organisms (the ‘playing God’ charge)? Is synthetic biology unacceptably 
‘unnatural’ in some sense? Does patenting the genome of a living being violate its dignity? Would synthetic 
organisms have lower moral status than natural counterparts, by virtue of their artefactual status? If it was 
thought that synthetic organisms were not worthy of moral consideration, and we were able to utilise them 
as we wished, what would this say about us, their creators? And do all or any of these constitute sufficient 
reason not to permit it? 
These are even bigger questions than those I posed earlier, and again, I do not pretend to have definite 
answers. Perhaps the best we can do is work them out publicly, and legislate accordingly. That, to me, would 
be truly responsible research and innovation. 
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Appendix 4 Images of Automation Technologies in Synthetic Biology 
 
Source: “Figure 1: Multiplex automated genome engineering (MAGE) processes and applications.” From 
Rapid editing and evolution of bacterial genomes using libraries of synthetic DNARyan R Gallagher, Zhe Li, 
Aaron O Lewis & Farren J Isaacs, Nature Protocols  9, 2301–2316 (2014) doi:10.1038/nprot.2014.082 
Published online  04 September 2014 
 
Source: “Figure 1: Concept of on-demand production of biologicals on the DBC.” from Digital-to-biological 
converter for on-demand production of biologics, Kent S Boles, Krishna Kannan, John Gill, Martina 
Felderman, Heather Gouvis, Bolyn Hubby, Kurt I Kamrud, J Craig Venter & Daniel G Gibson, Nature 
Biotechnology (2017) doi:10.1038/nbt.3859 Published online  29 May 2017 
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Source: “Supplementary Figure 3: Importance of error-correction reaction to produce functional DNA 
amplicons.” from Digital-to-biological converter for on-demand production of biologics, Kent S Boles, Krishna 
Kannan, John Gill, Martina Felderman, Heather Gouvis, Bolyn Hubby, Kurt I Kamrud, J Craig Venter & Daniel 
G Gibson, Nature Biotechnology (2017) doi:10.1038/nbt.3859 Published online  29 May 2017 
Source: “Supplementary Figure 1: Prototype of the digital-to-
biological converter (DBC).” from Digital-to-biological converter 
for on-demand production of biologics, Kent S Boles, Krishna 
Kannan, John Gill, Martina Felderman, Heather Gouvis, Bolyn 
Hubby, Kurt I Kamrud, J Craig Venter & Daniel G Gibson, Nature 
Biotechnology (2017) doi:10.1038/nbt.3859 Published online  29 
May 2017 
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Appendix 5 Artist Images “Blood Culture”: Reimagining Life at the Cellular level (Katy Connor, Artist in 
Residence, (BrisSynBio/ University of Bristol) 
 
 
Image: Katy Connor Language of Liquidity: Screen mono print on paper (2017) 
I use the process of screenprinting, as a vehicle to explore a physical response to being in the lab, where red 
blood cells are routinely cultured in a liquid medium of highly instrumental colour (phenol red). Here in these 
prints, the viscous media of paint, colour and chance become an antidote to containment. 
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Image: Katy Connor Language of Liquidity: Screen mono print on paper (2017) 
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Appendix 6 Slides of Presentation on Constructivist Biology 
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